Researchers receive €10.6 million to develop new therapeutic approaches to target glioblastoma

Researchers at the Universities of Amsterdam and Leiden together with the Netherlands Cancer Institute (Amsterdam) and Oncode Institute (Utrecht) have received a €10.6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma, a deadly primary brain tumor for which no curing therapy is yet available.

Reassessing the Health Star Rating: New study highlights need for ultra-processed food adjustments

Researchers reassess the Australian and New Zealand Health Star Rating (HSR) given the increasing prevalence of ultra-processed foods.

August 21, 2024

Newly identified protein plays a key role in the action of emerging anticancer therapies

Scientists have identified a protein that plays a pivotal role in the action of several emerging cancer therapies. The researchers say the discovery will likely

July 31, 2023

Takeda wins FDA approval for self-administered, subcutaneous Entyvio in ulcerative colitis

The FDA has approved a subcutaneous version of Takeda’s ulcerative colitis drug Entyvio, more than three years after rejecting the company’s application over what it

September 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.